Prevention and Control of Infectious Diseases in BRI Countries, 1st ed. 2021

Coordinator: Yang Weizhong

Language: English

Approximative price 73.84 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Prevention and Control of Infectious Diseases in BRI Countries
Publication date:
188 p. · 15.5x23.5 cm · Paperback

Approximative price 105.49 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Prevention and Control of Infectious Diseases in BRI Countries
Publication date:
Support: Print on demand

This book systematically assesses the risk of 21 major infectious diseases threatening BRI countries. It consists of 14 chapters. Chapter 1 is an overview. Chapter 2 introduces the history of health cooperation between China and other BRI countries. Chapters 3-14 introduce the prevalence of major infectious diseases threatening BRI countries such as cholera, vaccine preventable diseases (polio, measles, meningitis, Japanese encephalitis, diphtheria, hepatitis A), tuberculosis, influenza, and insect-borne diseases (Dengue fever, Zika virus disease, yellow fever, Chikungunya, Rift Valley fever), plague, malaria, Ebola virus disease, MERS, schistosomiasis, COVID-19 and AIDS, and  risk factors, principles and cases of their prevention and control.                     

It is a useful reference book in the research of infectious disease control and prevention, and provides historical experience and lessons learned. It also provides decision support for international cooperation among BRI countries in the field of epidemic prevention and control in the future.

1 Introduction 2 Health Cooperation between China and Other “Belt and Road” Countries 3 Cholera Risk Assessment, Control and Prevention 4 Risk Assessment and Control on Vaccine-Preventable Diseases 5 Risks of Tuberculosis Prevention and Control 6 The Risk and Prevention and Control of Influenza 7 The Risk, Prevention, and Control of Arthropod-borne Infectious Diseases 8 Plague Risk and Prevention 9 Malaria Risk and Control 10 Ebola Virus Disease Risk and Control 11 Risk and Prevention of Middle East Respiratory Syndrome (MERS) 12 Schistosomiasis Risk and Prevention 13 COVID-19 Risk and Control 14 Risk of AIDS and Its Prevention and Control

Professor Weizhong Yang, is Vice President of Chinese Preventive Medicine Association, Executive Dean of School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College and Vice President of the UN Consultative Committee on Life Science and Human Health (CCLH), China Association of Science and Technology (CAST).

Assesses the risk of 21 major infectious diseases in BRI Countries

Highlights infectious diseases as an important public health security problem globally

Compiles recent disease control and prevention experience